Masanori Shimoyama

Masanori Shimoyama's AcademicInfluence.com Rankings

Masanori Shimoyama

Philosophy

#9568

World Rank

#13149

Historical Rank

Logic

#6541

World Rank

#8066

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Masanori Shimoyama's Degrees

Doctorate Medicine University of Tokyo
PhD Medicine University of Tokyo

Why Is Masanori Shimoyama Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Masanori Shimoyama's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma (1991) (1308)
Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. (1991) (431)
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. (2007) (417)
A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303 (2001) (357)
Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. (1989) (282)
Multi‐step Carcinogenesis Model for Adult T‐cell Leukemia (1989) (203)
Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group. (1993) (172)
Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group. (1993) (146)
Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. (1988) (138)
Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay. (1983) (133)
Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia. (1983) (132)
Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. (1988) (131)
Randomized study of individualized induction therapy with or without vincristine, and of maintenance—intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML‐87 study of the Japan adult leukemia study group (1993) (110)
Immunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy, and IBL‐like T‐cell lymphoma: A spectrum of T‐cell neoplasia (1986) (94)
Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. (1988) (81)
Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study (JCOG9109) (2003) (81)
Adult T cell lymphoma with hypergammaglobulinemia (1980) (72)
Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors. (2000) (72)
Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long‐term survivors of aggressive adult T‐cell leukaemia‐lymphoma (JCOG0902A) (2014) (71)
Anti-ATLA (Antibody to the Adult T-Cell Leukemia Cell-Associated Antigen)-Positive Hematologic Malignancies in the Kanto District (1982) (68)
Adult T-cell leukemia/lymphoma not associated with human T-cell leukemia virus type I. (1986) (66)
Treatment of patients with adult T-cell leukemia-lymphoma: an overview (1992) (66)
Leukemic distribution of a human acute lymphocytic leukemia cell line (Ichikawa strain) in nude mice conditioned with whole-body irradiation. (1978) (66)
Genetic Alteration of p53 in Some Patients with Adult T‐Cell Leukemia (1991) (62)
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. (2002) (58)
Role of Epstein-Barr virus in pleural lymphomagenesis. (1995) (54)
Final Results of Cooperative Study of VEPA [Vincristine, Cyclophosphamide (Endoxan), Prednisolone and Adriamycin] Therapy in Advanced Adult Non-Hodgkin's Lymphoma: Relation Between T- or B-Cell Phenotype and Response (1982) (51)
Japan Clinical Oncology Group (JCOG). (1998) (49)
Prognostic factors and prognostic staging system for small cell lung cancer. (1997) (49)
Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma. (1983) (45)
Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma. (1991) (45)
Adult T‐Cell leukemia/lymphoma: A working point‐score classification for epidemiological studies (1994) (42)
Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group. (1992) (41)
A novel human myelomonocytoid cell line, P39/Tsugane, derived from overt leukemia following myelodysplastic syndrome. (1984) (39)
Artificial Pneumothorax as a Risk Factor for Development of Pleural Lymphoma (1993) (39)
PRODUCTION OF PARATHYROID HORMONE‐RELATED PROTEIN IN ADULT T‐CELL LEUKEMIA CELLS (1988) (37)
Expression of Epstein‐Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax‐associated lymphoma (1996) (36)
Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809. (2011) (32)
Chromosome aberrations and clinical features of adult T cell leukemia-lymphoma not associated with human T cell leukemia virus type I. (1987) (31)
Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T/natural killer-cell lymphomas (2010) (30)
Differences in prognostic factors between leukemia and lymphoma type of adult t‐cell leukemia (1989) (30)
Synergistic Effect of Cyclosporin A and Verapamil in Overcoming Vincristine Resistance of Multidrug‐resistant Cultured Human Leukemia Cells (1990) (30)
Immortalization of peripheral blood lymphocytes of cats by human T‐cell leukemia virus (1984) (28)
Treatment of acute myelogenous leukemia in adults with N4‐behenoyl‐1‐β‐D‐arabinofuranosylcytosine (1985) (28)
Cytocidal action of anticancer antigens: evaluation of the sensitivity of cultured animal and human cancer cells. (1975) (27)
Infectious states of human T lymphotropic virus type I and hepatitis B virus among Japanese immigrants in the Republic of Bolivia. (1988) (26)
Prognostic Significance of CD7+CD56+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0 (2003) (25)
A Phase I/II Study of Continuous Intra-arterial Chemotherapy Using an Implantable Reservoir for the Treatment of Liver Metastases from Breast Cancer: A Japan Clinical Oncology Group (JCOG) Study 9113 (1999) (24)
Multidrug Resistance in Cultured Human Leukemia and Lymphoma Cell Lines Detected by a Monoclonal Antibody, MRK16 (1989) (24)
Cellular Origin of Human Lymphoid Malignancies as Based on Immunologic Analysis of Membrane Differentiation Antigens (1982) (22)
Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma. Lymphoma Study Group of the Japan Clinical Oncology Group. (1995) (22)
Lymphoma study group of JCOG. (2012) (22)
Methylation pattern of human T‐cell leukemia virus in vivo and in vitro: pX and LTR regions are hypomethylated in vivo (1985) (22)
A novel pre-T cell line derived from acute lymphoblastic leukemia. (1982) (21)
Differences in clinicopathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia/lymphoma. (1993) (21)
The Differences between Lymphoma and Leukemia Type of Adult T-cell Leukemia. (1990) (21)
Prognostic factors for pleural lymphoma patients. (1991) (21)
Growth inhibitory activity of human lymphoblastoid and fibroblast interferons in vitro. (1983) (21)
Cancer superimposed on adult T‐cell leukemia (1989) (21)
Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites. (1986) (21)
Failure to Detect Epstein-Barr Virus (EBV) DNA in Plasma by Real-Time PCR in a Case of EBV-Associated Posttransplantation Lymphoproliferative Disorder Confined to the Central Nervous System (2002) (20)
Studies with multiple markers on malignant lymphomas and lymphoid leukemias (1982) (20)
Quantitative autoradiographic localization of the M1 and M2 subtypes of muscarinic acetylcholine receptors in the monkey brain. (1989) (19)
Adult T-cell leukemia/lymphoma and its clinical subtypes from the viewpoints of viral etiology. (1985) (19)
Primary peripheral T‐cell lymphoma, not otherwise specified of the thyroid with autoimmune thyroiditis (2013) (19)
Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T‐cell leukemia‐lymphoma (2014) (18)
A novel monocytoid cultured cell line, P31/Fujioka, derived from acute monoblastic leukemia. (1982) (18)
Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncolog (2000) (18)
Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M). (1988) (16)
A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin’s Lymphoma: Japan Clinical Oncology Group Study 9002 (2004) (16)
Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor. (1995) (15)
Mg2+-dependent adenosine triphosphatase as an enzyme histochemical marker for the lymphomas of B-cell origin. (1979) (15)
Peripheral T-cell lymphoma in Japan: recent progress. (1991) (15)
Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan (2010) (15)
Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma (1988) (15)
Prevalence of antibodies to human T-cell leukemia/lymphoma virus type I and human immunodeficiency virus in Japanese immigrant colonies in Bolivia and Bolivian natives. (1987) (15)
Long-term Follow-up Results of Adult Patients with Acute Lymphocytic Leukemia or Lymphoblastic Lymphoma Treated with Short-term, Alternating Non-cross-resistant Chemotherapy: Japan Clinical Oncology Group Study 8702 (1999) (14)
STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas (2015) (14)
A Novel Multidrug Resistance in Cultured Leukemia and Lymphoma Cells Detected by a Monoclonal Antibody to 85‐kDa Protein, MRK20 (1989) (14)
Phase II study of ABVd therapy for newly diagnosed clinical stage II–IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305) (2010) (14)
Adult T‐cell leukemia/lymphoma (ATL) –clinical, histopathological, immunological and immunohistochemical characteristics (1992) (13)
Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. (1994) (13)
Anti-ATLA (antibody to adult T-cell leukemia-lymphoma virus-associated antigen)-negative adult T-cell leukemia-lymphoma. (1983) (13)
Quantitative clonal growth of mammalian cells: its application for quantitative study of cytocidal action of Mitomycin-C. (1972) (13)
Ribosome-lamella complex of the lymphocytes in a case of plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia. (1984) (13)
Time-dependent cytotoxic action of human recombinant alpha-interferon (Ro22-8181) in vitro and the sensitivity of various cultured leukemia and lymphoma cell lines to it. (1985) (13)
Analyses of adult T-cell leukemia using the monoclonal (anti-Leu-1, anti-Leu-2a, and anti-Leu-3a) and heterologous anti-glycolipid (anti-asialo GM1) antibodies. (1982) (12)
Antitumor activity of quinocarmycin (KW2152) against various cultured leukemia and lymphoma cell lines in vitro. (1988) (12)
Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents (2015) (12)
The status of antithymocyte globulin therapy for adult patients in Japan: retrospective analysis of a nationwide survey (2008) (12)
Two novel cultured cell lines, A3/Kawakami and A4/Fukuda, derived from malignant lymphoma of B(non-T)-cell nature of the gastrointestinal tract. (1983) (12)
Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies. (1983) (11)
A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) study 9113. JCOG Breast Cancer Study Group. (1999) (11)
Non‐Hodgkin lymphoma of the skin excluding mycosis fungoides and cutaneous involvement of adult T‐cell leukemia/lymphoma * (1988) (10)
Phenotypic Heterogeneity of Lymphoma of the Skin (1989) (10)
The role of lysosomes in cancer chemotherapy. II. Effect of mitomycin-C injection on lysosomal enzymic activities of Yoshida ascites sarcoma cells. (1966) (10)
Monoclonal antibodies and immunodiagnosis of leukemia/lymphoma. (1985) (10)
Molecular genetic and immunohistochemical analyses of a case of multicentric Castleman's disease. (1988) (10)
Genetic and clinical studies of Japanese patients with familial amyloid polyneuropathy. (1989) (10)
Cellular origin, differentiation and classification of leukemia and lymphoma cells as based on surface marker analysis. (1979) (9)
[Coexisting malignant lymphoma and advanced adenocarcinoma of the colon--a case report]. (1985) (9)
Report of the Seventh International Symposium of the Foundation for Promotion of Cancer Research: fundamental and clinical research in lung cancer. (1994) (9)
Lymphoma and leukemia of t-lymphocytes. (1981) (9)
Second primary malignancies in lymphoma patients. (1985) (9)
Cellular Origin of T Cell Malignancies (1982) (8)
Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301 (2004) (8)
Relationship between methylation of the p15 gene and ectopic expression of the EVI-1 gene in myelodysplastic syndromes (MDS). (2001) (8)
Cyclocytidine-A Phase I Study (1972) (8)
THE ROLE OF LYSOSOMES IN CANCER CHEMOTHERAPY (1966) (8)
[Clinical, cytological and immunological analysis of T-cell type lymphoid malignancies: a classification of T-cell type lymphoid malignancy (author's transl)]. (1979) (7)
T Cell Lymphomas in Relation to Subpopulation of T Lymphocytes (1982) (7)
[EFFECT OF MITOMYCIN-C INJECTION ON LYSOSOMAL ENZYMIC ACTIVITIES OF YOSHIDA ASCITES SARCOMA]. (1964) (7)
Concurrent adult T-cell leukemia and acute myeloblastic leukemia. (1988) (7)
The Reaction Specificity of Various Monoclonal Antibodies and Cellular Origin and Differentiation of Cultured Cell Lines Derived from Human Leukemias and Lymphomas (1981) (7)
Effect of cerulein on in vivo release of acetylcholine from the rat striatum (1989) (7)
A phase II study of induction chemotherapy (Ind CT) with CPT-11 and cisplatin followed by thoracic radiation (TRT) combined with weekly CPT-11 in patients with unresectable stage III non-small-cell lung cancer (NSCLC): A Japan Clinical Oncology (JCOG) 9706 Trial (2000) (7)
A B-lymphoma cell line that forms rosettes with neuraminidase-treated sheep erythrocytes through monoclonal surface immunoglobulin. (1982) (7)
Growth-inhibitory activity of human recombinant β-interferon (GKT-β) in vitro (1984) (7)
Severe herpes simplex virus hepatitis following autologous bone marrow transplantation: successful treatment with high dose intravenous acyclovir. (1991) (7)
Influence of fetal calf serum on growth-inhibitory activity of human recombinant gamma-interferon (GI-3) in vitro. (1986) (7)
Terminal deoxynucleotidyl transferase activity in leukemia and lymphoma, with special reference to adult T cell related neoplasms. (1980) (7)
Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-Cell Leukemia-Lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801. (2005) (6)
Quinazoline antifolates: dosage schedules and toxicity. (1971) (6)
A novel Japanese Burkitt's lymphoma cell line, P32/Ishida, with a new variant chromosomal translocation (2;14). (1983) (6)
A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients: Japan Clinical Oncology Group Study JCOG9203 (2006) (6)
Binding experiments of muscarinic acetylcholine and dopamine receptors in human brains with emphasis on a case of striatonigral degeneration. (1982) (6)
A SOLUBLE‐FACTOR(S) SECRETED BY A HUMAN SKIN CANCER CELL LINE SUPPORTS CLONAL GROWTH OF ADULT T‐CELL LEUKEMIA CELLS (1988) (6)
Proceedings of the international round table conference: FAB classification of acute leukemias correlating with response to chemotherapy. (1984) (6)
Monoclonal antibody studies in B(non-T)-cell malignancies. (1983) (6)
Chromosomal aberrations in adult T-cell leukemia-lymphoma: summary of a karyotype review committee report (1992) (6)
Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508 (2012) (6)
Potential limitation of growth-inhibitory action of recombinant human tumor necrosis factor (PAC-4D) due to easy induction of resistance: evidence in vitro. (1987) (5)
Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705) (2013) (5)
A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group. (1997) (5)
Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402. (2012) (5)
Cardiac Disorders and Autonomic Nervous System Involvement in Familial Amyloidosis (1986) (5)
Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults. (1993) (5)
Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group. (1998) (4)
Immunologic Characterization of Reed‐Sternberg Cells and Other Cell Components in Lymph Nodes With Hodgkin's Disease (1984) (4)
Treatment of acute leukemia and malignant lymphoma with (2″R)-4′-O-tetrahydropyranyladriamycin (2004) (4)
A unique T-cell line derived from an HTLV-1-negative adult T-cell leukemia patient. (1987) (4)
The role of lysosomes in cancer chemotherapy. 3. Influence of plasmin on the lysosomes of tumor cells and on the cytocidal effect of mitomycin-C. (1969) (4)
[Echographic features of malignant lymphoma. Clinical application of ultrasonic echography for the evaluation of abdominal tumor regression during chemotherapy (author's transl)]. (1975) (4)
Karyotype aberrations and surface marker analyses of the tumor cells of Hodgkin's disease: a case report and review of literature. (1986) (4)
Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma: clinico-pathologic, immunophenotypic and immunogenotypic analyses. (1987) (4)
Prognosis of non-Hodgkin's lymphoma 1. T- and B-lymphoma and its primary site.:1. T- and B-lymphoma and its primary site (1985) (4)
[Human T-cell leukemia virus type I and adult T-cell leukemia-lymphoma]. (1990) (4)
Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group. (1992) (4)
Clinical significance of major and minor bcr/abl chimeric transcripts in essential thrombocythemia. (2000) (4)
Non-T Cell Lymphoma and Chronic Lymphocytic Leukemia: Immunologic and Clinicopathologic Study (1980) (4)
Immunologic, Clinicopathologic and Prognostic Features of Lymphoma of the Gastrointestinal Tract (1981) (4)
The role of lysosomes in cancer chemotherapy. I. A study of lysosomal enzymes in Yoshida ascites sarcoma cells. (1966) (3)
Antileukemic activity of the 2,4-diaminoquinazoline antifolates, quinazoline resistant sublines of l1210 mouse leukemia. Abstr. (1969) (3)
Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group. (1999) (3)
[Recent progress in non-Hodgkin's lymphoma study in Japan]. (1988) (3)
Characterization of Long-Term Survivors and a Predictive Model for Aggressive Adult T-Cell Leukemia-Lymphoma (ATL): An Ancillary Study by the Japan Clinical Oncology Group, JCOG0902A (2011) (3)
Factors Influencing Transfused Platelet Recovery and Survival, With Special Reference to Antiplatelet Antibody (1977) (3)
Antibodies to human immuno-deficiency virus and human T-cell leukemia virus type I in Japanese patients with hematologic malignancies. (1986) (3)
[Recent advances in clinical research on T-cell lymphoma]. (1990) (2)
[A novel cultured cell line (P30/Ohkubo) of pre-T cell (C/T hybrid) phenotype derived from an acute lymphoblastic leukemia with some phenotypic change during clinical course]. (1983) (2)
[Prognosis of non-Hodgkin's lymphoma. 2. T- and B-lymphoma and clinical stage]. (1985) (2)
[The clinical effects of a new antiviral 9-(2-hydroxyethoxymethyl) guanine (aciclovir) against herpes virus infections]. (1983) (2)
Prognostic factors and therapeutic results in multiple myeloma. (1985) (2)
[Determination of the surface properties]. (1979) (2)
Growth-inhibitory activity of human recombinant beta-interferon (GKT-beta) in vitro. (1984) (2)
[Contributing factors to the development of congenital myotonic dystrophy]. (1988) (2)
Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group. (1999) (2)
QUANTITATIVE CLONAL GROWTH OF MAMMALIAN CELLS (1972) (2)
Effects of 3-methyl-1-(5-oxohexyl)-7-propylxanthine on the in vivo release of monoamines studied by intracerebral dialysis. (1988) (2)
Effect of blood, ascites, and tumor cell density on cytocidal action of neocarzinostatin. (1979) (2)
[The specificity of antisera produced in rabbits against human leukemia cells, cultured lymphoblastoid and myeloid cells (author's transl)]. (1980) (2)
[5 Cases of immunoblastic lymphadenopathy (IBL)- like T cell lymphoma-a report on the clinical, histopathological and immunological investigations]. (1983) (2)
Phase I clinical and pharmacokinetic study ofN4-behenoyl-1-β-d-arabinofuranosylcytosine (1986) (2)
[Prognosis of non-Hodgkin's lymphoma. 3. Clinical and pathological diagnosis of T- and B-lymphoma and its staging]. (1985) (2)
[A clinical study of non-Hodgkin's lymphoma of the nasal cavity and paranasal sinus]. (1988) (1)
Differences in Prognostic Factors between Diffuse Non-Hodgkin's Lymphoma and Lymphoma Type of Adult T-Cell Leukemia. (1990) (1)
[Two novel cultured cell lines, A3/Kawasaki and A4/Fukuda, derived from malignant lymphomas of the gastrointestinal tract]. (1983) (1)
[On the significance of multiagent combination chemotherapy for primary gastric malignant lymphoma (author's transl)]. (1981) (1)
[Lymphocyte blast formation]. (1979) (1)
[Adenosine deaminase and purine nucleoside phosphorylase activities of various cultured cell lines derived from human hematologic malignancies]. (1981) (1)
Cell surface markers of acute non-lymphocytic leukemias: leukemia type and its expression of C3 and Fc receptors. (1986) (1)
[Tumor markers--personal experience. A case of advanced extragonadal germ-cell tumor showing complete remission by high-dose combination chemotherapy with autologous bone marrow transplantation]. (1991) (1)
[Hairy cell leukemia with a 14q+ dueto 14; 22 reciprocal translocation]. (1987) (1)
[Establishment of a novel cultured cell line, P31/Fujioka, of monocytoid nature]. (1983) (1)
Pathological Sutdies on Familial Amyloidosis (1988) (1)
Potentiation of Growth‐inhibitory Activity of 9‐β‐d‐Arabinofuranosyladenine by 2′‐Deoxycoformycin in Human Cultured Cell Lines Derived from Leukemias and Lymphomas (1989) (1)
[T-cell type reticulum cell sarcoma.--Report of a case with autopsy-- (author's transl)]. (1977) (1)
Immunologic Phenotype of Tumor Cells from Japanese T Cell Malignancies (1984) (1)
Clinical implications of anti-HTLV antibody titer, abnormal lymphocytes in HTLV carriers and HTLV genome negative adult T-cell leukemia-lymphoma. (1984) (1)
[A case of acute leukemia associated with Down's syndrome showing myeloid and lymphoid markers (author's transl)]. (1980) (1)
Structure of HTLV and its biological function in leukemogenesis of adult T-cell leukemia. (1986) (1)
A Case of Heavy Chain Disease (1971) (1)
[A case of "monocytic sarcoma of the peritoneal type" with minimal involvement of the bone marrow, liver, spleen, and lymph node (author's transl)]. (1978) (1)
Summary of the Symposium on B-Cell Malignancies (1983) (1)
Oil-Depot Type Bleomycin in the Treatment of Malignant Lymphoma in Comparison with Regular Bleomycin (1978) (1)
[Analysis of membrane-associated antigen of human lymphatic neoplasms and its cellular origin using various monoclonal antibodies]. (1982) (1)
[Chemotherapy of malignant abdominal tumors--with special reference to gastric cancer]. (1967) (1)
Non-Hodgkin's lymphoma in patients under twenty years of age. A clinicopathological study. (1991) (1)
Diagnosis of Familial Amyloid Polyneuropathy by Recombinant DNA Techniques in Relation with Clinical Features (1988) (1)
Standard CHOP therapy for low (L) or low-intermediate (L-I) risk patients (pts) with aggressive non-Hodgkin's lymphoma (NHL): A multicenter phase II study by Japan Clinical Oncology Group (JCOG 9508). (2004) (1)
[Recent progress in the treatment of malignant lymphoma]. (1994) (1)
[Need to establish academic research organization for cancer clinical trial and clinical research system having clinical investigators and study coordinators, with special reference to promotion of medical and life science research policy]. (1999) (1)
[Treatment and prognosis of acute leukemia]. (1965) (1)
Natural History of Ogawa Village Type Familial Amyloid Polyneuropathy in Japan (1988) (1)
An Enzyme- and Immunohistochemical Study of Malignant Lymphomas (1981) (1)
Peripheral T-Cell Lymphoma-Unspecified (PTCL-U) and NK/T-Cell Lymphoma Showed a Significantly Poor Prognosis in a Randomized Controlled Trial (RCT) JCOG9002 with Multidrug Combination Chemotherapy for Aggressive Lymphoma. (2006) (1)
[HTLV-I negative adult T cell leukemia; a case report of acute type]. (1993) (1)
Phase II Study of Chemotherapy (Cx) and Stem Cell Transplantation (SCT) for Adult Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LBL): Long-Term Follow-up Results of Japan Clinical Oncology Group (JCOG) Study 9402. (2009) (1)
[Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma]. (1994) (1)
Peripheral T-cell lymphoma (1988) (1)
[Detection of multidrug resistant phenotype in leukemia and lymphoma by monoclonal antibodies]. (1988) (1)
[The significance of reinduction chemotherapy with adriamycin for relapsed non-Hodgkin's lymphoma of Waldeyer's ring]. (1985) (0)
[Stimulating capacity of tumor cells from lymphocytic leukemia and non-Hodgkin lymphoma in allogenic 'one-way' mixed lymphocyte tumor cell reaction (author's transl)]. (1981) (0)
Important Prognostic Factors of 447 Cases of Non-Hodgkin's Lymphoma Reviewed by Hematopathologists (1998) (0)
[Treatment of malignant lymphoma]. (1989) (0)
[VEPA therapy in B-lymphoma]. (1986) (0)
[Factors influencing transfused platelet recovery and survival, especially antiplatelet antibody (author's transl)]. (1977) (0)
Application of recent diagnostic analysis. Cellular origin of non-Hodgkin's lymphoma. (1984) (0)
[Principles of and instruments for a continuous-flow blood cell separator---centrifugation]. (1977) (0)
[Surface markers and clinico-pathological characteristics of lymphoproliferative malignancies (author's transl)]. (1978) (0)
[History of research on malignant lymphoma]. (2002) (0)
[Hodgkin's disease under twenty years of age--clinicopathological study]. (1989) (0)
[Malignant lymphoma--recent progress in diagnosis and treatment. 2. Application of recent diagnostic analysis. (1). Cellular origin of non-Hodgkin's lymphoma]. (1983) (0)
[Introduction of anticancer agents to phase I clinical trials]. (1997) (0)
Leukemia.Advance of diagnosis and treatment.3.A treatment.7.Multiple-drug resistance of anticancer drug and its conquest. (1992) (0)
[Major prognostic factors in patients with T- and B-cell lymphomas]. (1989) (0)
Mutation study of the BCL10 gene in lymphoma with both RNA and DNA (2001) (0)
Guideline for clinical safety data management in Japan Clinical Oncology Group (JCOG) (version 4) (2001) (0)
Effects of Granulocyte Transfusion and Combination Antibiotic Therapy on Documented Septicemia in Patients with Acute Leukemia (1979) (0)
[Smoldering ATL appeared in the course of collagen disease-like symptoms. Followed by the crisis and death]. (1986) (0)
HODGKIN'S DISEASA : REVIEW OF PATHOLOGY MATERIAL FROM A PROTOCOL STUDY (JCOG8905) (1997) (0)
Establishment and characterization of 10 cell lines derived from patients with adult T-eell leukemia ( human retrovirus / T-cell growth factor / surface marker / immunofluorescence / Southern blot hybridization ) (1999) (0)
[The effect of granulocyte transfusions on septicemia in patient with acute leukemia (author's transl)]. (1979) (0)
[Cytotoxic activity of fresh rabbit serum (complement) against various cultured lymphoblastoid cell lines and its removal (author's transl)]. (1980) (0)
Inference of cellular origin and differentiation stage of B-cell malignancies using multiple immunological markers. (1984) (0)
[Formation of anti-leukocyte antibody and anti-platelet antibody and its effects on blood component transfusion]. (1977) (0)
Review on internal medicine(1988). Recent progress in treatment of haematological malignancies. V. Lymphoproliferative disease. 1) Recent results of chemotherapy and major prognostic factors in patients with T-cell lymphoma, B-cell lymphoma and hodgkin's disease. (1989) (0)
[Clinical studies of leukemic non-Hodgkin's lymphoma. II. Clinicopathological aspects and prognostic factors]. (1983) (0)
[Effect of combined therapy with lysosome labilizer and antineoplastic agents with reference to increased effect of mitomycin C by lipoprotein lipase]. (1970) (0)
[The treatment of advanced non-Hodgkin's lymphoma with adriamycin (author's transl)]. (1978) (0)
Establishment andcharacterization of10cell lines derived from patients withadult T-eell leukemia (1983) (0)
[Screening test of antitumor agents by human tumor cell lines in nude mice in ascitic form]. (1984) (0)
Title STX 11 functions as a novel tumor suppressor gene inperipheral T-cell lymphomas (2019) (0)
[Prognostic factors and predictive model of malignant lymphoma]. (1994) (0)
[Detection of multidrug resistant cells in human malignant diseases by monoclonal antibodies and strategy to eradicate resistant malignant cells]. (1989) (0)
Control of crown rot of sugar beet with PCNB (1963) (0)
[High dose chemotherapy with autologous bone marrow transplantation and G-CSF for hematologic malignancies]. (1992) (0)
Phase I--II study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine. (1981) (0)
[Case of immunoblastic lymphadenopathy (IBL)-like T cell lymphoma]. (1982) (0)
Adult T Cell Leukemia and Related Diseases (2012) (0)
[Cross and non-cross resistant anticancer agents to multidrug-resistant cultured cells from hematologic malignancies]. (1989) (0)
A study on anti-ATLA antibody in Nagano Prefecture. (1985) (0)
[Prognosis of non-Hodgkin's lymphoma. 1. T- and B-lymphomas and their primary sites]. (1985) (0)
[Recent progress in the treatment of hematological malignancies. V. Recent results of chemotherapy and major prognostic factors in patients with T-cell lymphoma, B-cell lymphoma and Hodgkin's disease]. (1989) (0)
2-(1) Cellular Origin of Non-Hodgkin's Lymphoma (1984) (0)
[Stimulating capacity of cultured human lymphoid and myeloid cells in allogenic 'one-way' mixed lymphocyte tumor cell reaction (author's transl)]. (1980) (0)
Effects of cerulein on the in vivo release of dopamine from rat striatum (1988) (0)
[Review of recent studies on the lysosome and its application for cancer therapy]. (1966) (0)
Lecture Cellular and molecular neuroscience Transmitter releaseInfluence of glucocorticoid on neurotransmitter release in the rat hippocampus (1991) (0)
[Analysis of membrane differentiation antigens and ATLA (adult T-cell leukemia virus-associated antigen) of 25 cultured cell lines derived from human T-cell leukemia/lymphoma]. (1984) (0)
Low Serum Total Protein and Unfavorable Pathological Subtype Are Independent Unfavorable Factors in Peripheral T-Cell Lymphoma (PTCL) Treated in Prospective Clinical Tirals; Japan Clinical Oncology Group (JCOG) 0108A Study. (2007) (0)
Prognostic Analysis of Hodgkin Lymphoma (HL) in JAPAN (2008) (0)
[Growth inhibition activity of human lymphoblastoid interferon]. (1983) (0)
[Evaluation of cardiotoxicity in new anthracycline analog ME 2303. ME 2303 Study Group]. (1991) (0)
[The management of Hodgkin's disease with chemotherapy or combined modality treatment]. (1998) (0)
[Development of lymphocytotoxic antibody and antiplatelet antibody following blood transfusion and their clinical significance in platelet transfusion (author's transpl)]. (1978) (0)
Phase II Study of Intensive Post-remission Chemotherapy and Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma : Japan Clinical Oncology Group Study , JCOG 9402 (2012) (0)
Special issue : Lymphoproliferative disease.Lymphoproliferative diseases : An advance on diagnosis and treatments.Treatments.Convalescence factors and convalescence prediction models of malignant lymphoma treatment. (1994) (0)
[Guideline for phase I study on new anticancer agents]. (2001) (0)
sheep erythrocytes through monoclonal surface immunoglobulin A B-lymphoma cell line that forms rosettes with neuraminidase-treated (2012) (0)
Intracellular Transcobalamins in Various Cultured Cell Lines Established from Hematological Malignancies (1982) (0)
[Abnormal lymphocytes in HTLV infections and its clinical significance]. (1986) (0)
Relationship between methylation of the p15 gene in myelodysplastic syndromes (MDS) (2001) (0)
[Immunologic phenotype of malignant lymphoma]. (1992) (0)
[Combination chemotherapy of primary gastric lymphoma with vincristine, endoxan (cyclophosphamide), prednisolone and adriamycine (VEPA)]. (1982) (0)
[The surface markers of non-Hodgkin's disease cells; classification of T and B cell lymphoma and their prognosis]. (1985) (0)
High dose chemotherapy followed by autologous bone marrow transplantation (ABMT) and daily infusion of granulocyte colony stimulating factor (G-CSF) for malignant tumors in adults. (1991) (0)
[Secondary acute leukemia in cancer patients]. (1986) (0)
[A preliminary study of vincristine, methotrexate, and prednisolone (VM*P) combination chemotherapy for advanced adult non-Hodgkin's lymphoma]. (1982) (0)
Molecular Biologyof Cancer: Implications for Prevention and Therapyâ€”Third Joint Meeting of the American Associationfor Cancer Research and the Japanese Cancer Association (2006) (0)
[Classification of leukemic cells with immunologic markers]. (1980) (0)
[Intracellular transcobalamins in various cultured cells established from hematological malignancies (author's transl)]. (1981) (0)
[Mode of recurrence and prognosis on non-Hodgkin's lymphoma of Waldeyer's ring]. (1984) (0)
[Antitumor activity of human interferons: their direct cytotoxic activity and clinical effects]. (1983) (0)
[Screening of antileukemic agents in transplanted human leukemic cells in nude mice]. (1981) (0)
Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A (2021) (0)
Four Cases of T-Cell Malignancy in Childhood (1979) (0)
[Detection of anti-ATLA (adult T-cell leukemia virus-associated antigen) in the sera of lymphoid malignancies in Kanto area]. (1983) (0)
Histochemical and Cytochemical Observations on Normal and Neoplastic T Lymphocytes (1982) (0)
STX11 Acts As a Novel Tumor Suppressor Gene in Peripheral T-Cell Lymphomas (2014) (0)
[An autopsy case of Waldenström's macroglobulinemia with pyroglobulin, cryoglobulin and hyperviscosity syndrome (author's transl)]. (1980) (0)
Primary gastric lymphoma: Treatment results and prognostic factors. (1990) (0)
[Effect of combination chemotherapy with adriamycin in elderly non-Hodgkin's lymphoma patients]. (1988) (0)
[Acrodystrophic neuropathy in an alcoholic]. (1993) (0)
[Clinical studies of leukemic non-Hodgkin's lymphoma. I. Leukemic conversion factors]. (1983) (0)
[Effects of granulocyte and platelet collection by semicontinuous plasmapheresis equipment (Hemonetics model 30) on blood donors: with special reference to the effects of high molecular hydroxyethyl starch]. (1981) (0)
[Clinical experience with procarbazine in malignant lymphomas--single and combination (VENP) therapy]. (1973) (0)
[Clinical features of Hodgkin's disease with special reference to evolution pattern of the lymph node involvement (author's transl)]. (1980) (0)
[The reaction specificity of various monoclonal antibodies against cultured cell lines derived from human leukemias and malignant lymphomas]. (1982) (0)
[Drug therapy of hematologic malignancy]. (1996) (0)
[Clinical studies of leukemic non-Hodgkin's lymphoma. III. Weight of leukemic conversion and prognostic factors]. (1983) (0)
[The effects of leucapheresis and plateletpheresis using celltrifuge and Haemonetics Model 30 on normal donors (author's transl)]. (1979) (0)
[Biology and clinical relevance of multidrug resistance associated antigen]. (1996) (0)
[Factors affecting the results of massive leukocyte transfusions]. (1977) (0)
B cell acute lymphoblastic leukemia (ALL) associated with alterations in surface and biochemical markers. (1983) (0)
[Clinical study of the septicemia in patients with leukemia and its antibiotic therapy (author's transl)]. (1979) (0)
Immunodiagnosis of Acute Lymphoblastic Leukemia: Lineage Specific Classification (1987) (0)
[Reaction specificity of monoclonal antibodies made from cell fusion method, with special reference to hemopoietic cells]. (1981) (0)
[Combined chemo-radiation therapy in adult patients with B-cell lymphoma in stage I and II]. (1988) (0)
[Treatment of malignant lymphoma with depot-type bleomycin (oil bleomycin) in comparison with regular bleomycin (author's transl)]. (1978) (0)
[Immunologic phenotype of acute leukemia, with reference to FAB classification of acute leukemia]. (1982) (0)
Activity and clinical effects.] (jap., Eng. Summ.) (1983) (0)
[Granulocyte collection by a semicontinuous flow blood cell separator (Heamonetics Model 30)]. (1978) (0)
Detection of drug resistance in human hematologic malignancy by monoclonal antibodies. (1988) (0)
lymphoma not associated with human T cell leukemia virus type I Chromosome aberrations and clinical features of adult T cell leukemia (2011) (0)
[An autopsy case of cutaneous T-cell lymphoma with gamma-chain in serum and urine preceded by collagen disease]. (1984) (0)
Re-evaluation of specificities of anti-myeloid-cell antibodies. (1987) (0)
[Drug resistance and a strategy to eradicate resistant malignant cells]. (1989) (0)
[Six cases of Ia-like antigen positive T cell lymphomas with skin lesions (author's transl)]. (1981) (0)
[Stimulating capacity of leukemia cells from acute non-lymphocytic leukemia, chronic myelogenous leukemia, blastic crisis of chronic myelogenous leukemia, and chronic myelomonocytic leukemia in allogenic 'one way' mixed lymphocyte tumor cell reaction (author's transl)]. (1980) (0)
A Phase II Clinical Trial of Recombinant Interferon-γ on Myelodysplastic Syndromes (1992) (0)
Interactions between dopamine and cerulein in the rat brain in vivo, studied by intracerebral dialysis (1988) (0)
[Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials]. (1993) (0)
[Malignant lymphoma--classification and pathophysiological characteristics of neoplastic cells based on the nature of cell membrane]. (1976) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Masanori Shimoyama?

Masanori Shimoyama is affiliated with the following schools: